Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough ...

The clinical nurse specialist in uro-oncology is undervalued and underdeveloped, according to a discussion paper on the role of this clinician.

Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized ...

Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 ...

TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene ...